ArticleAnnals of the rheumatic diseases2022

Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.

Pier Leopoldo Capecchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.